Borderline Resectable Pancreatic Ductal Adenocarcinoma
📧 Sign up to get email alerts when something new happens for Borderline Resectable Pancreatic Ductal Adenocarcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-01Clinical Trial Update: NALIRIFOX Before Surgery for the Treatment of Borderline Resectable Pancreatic Ductal Adenocarcinoma, Nectar Trial [Phase 2]
Phase 2 trial update for Nal-IRI–based therapy (NalIRIFOX) before surgery in borderline resectable pancreatic ductal adenocarcinoma; the stu…
-
CLINICAL_TRIALS research · 2026-01-16Clinical Trial Update: Using Tumour DNA and Proteins to Better Understand How Pancreatic Cancer Responds to Treatment [NA]
This clinical trial update describes a biomarker-focused study using tumor DNA and protein profiling to understand how pancreatic ductal ade…
-
CLINICAL_TRIALS research · 2025-08-01Clinical Trial Update: Determining the Link Between Dietary Patterns, Fecal Microbiome and Response to Neoadjuvant Chemotherapy
An Emory University-led trial is exploring how dietary patterns and the fecal microbiome affect response to neoadjuvant chemotherapy in pati…